Skip to main content

J. Goldman & Co LP

Position in CAPR — Capricor Therapeutics, Inc.

CIK 1412741 NEW YORK, NY

Position in CAPR

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$16,462,268
-$720,283 QoQ
Shares Held
541,522
-9.0% QoQ
Ownership
0.935%
of shares outstanding
% of Portfolio
0.81%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in CAPR Over Time

Shares Held

Position Value (USD)

Derivatives in CAPR

reported options exposure · as of Mar 31, 2026
CallValue
$608,000
CallShares
20,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

J. Goldman & Co LP holds $186,196,918 across 52 Biotechnology names. CAPR ranks #5 (8.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
5 CAPR
Capricor Therapeutics, Inc.
This page
541,522 $16,462,268

All Filings in CAPR

Export CSV
6 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $16,462,268 541,522
2026-03-31 $608,000 20,000
2025-12-31 $8,020,194 277,900
2025-12-31 $17,182,551 595,376
2025-09-30 $973,350 135,000
2025-09-30 $3,475,083 481,981